Skip to main content
JADPRO Live Virtual Event Banner
* indicates a required field

Welcome to Abstract Submissions

JADPRO Live Virtual

Thank you for your interest in submitting an abstract for JADPRO Live Virtual, a CE-accredited conference for advanced practitioners in oncology and hematology. Conference attendees will include nurse practitioners, physician assistants, clinical nurse specialists, pharmacists, advanced degree nurses, hematology/oncology nurses and physicians. The conference chair invites oncology advanced practitioners who are members of the Advanced Practitioner Society for Hematology and Oncology to submit abstracts to be considered for virtual poster presentation.

The abstract submission period for JADPRO Live Virtual is now closed.

Abstract submitters must complete all submission requirements by 11:59pm EDT on August 15, 2020 for the abstract to enter the review process and be considered for virtual poster presentation. An abstract deadline extension is not planned. There will be no additional deadlines for late-breaking data.

Abstract Submitter Requirements
The abstract submitter must meet the following requirements:
  • Be an oncology/hematology advanced practitioner (AP) defined as a nurse practitioner (NP), physician assistant (PA), pharmacist (PharmD), clinical nurse specialist (CNS), or master's degree or higher advanced practice nurse;
  • be a member of the Advanced Practitioner Society for Hematology and Oncology (APSHO) in good standing (please see below for more information);
  • complete all requirements of abstract submission, and
  • attend the virtual conference and present a poster should the abstract be accepted.
It is anticipated that the abstract submitter, the lead author and the poster presenter (should the abstract be accepted) are one and the same.

Information Required for Abstract Submission
An abstract submission must include the following information by the deadline to enter the review process:
  • Full name, credentials, title/position, institution, email, phone number and APSHO membership number of the submitting author
  • Full name, credentials, title/position, institution, email and phone number of each co-author
  • Final abstract title
  • Complete body of abstract including appropriate sub-headings
  • Permissions if applicable (may be uploaded as supporting documentation)
  • Completed Copyright Transfer Agreement for Abstracts (lead or representative author approved by the lead author must complete)
  • Completed Disclosure Forms (all authors listed on the abstract must complete)
  • Curriculum vitae (CV) or resume of submitting author
  • Declaration of the role of the authors in the work/content presented in the abstract
  • Confirmation of original authorship completed by submitting author
Providing references during the submission process is encouraged but not required; abstract submitters will have an opportunity during submission to upload references essential for review, along with necessary permissions, via a supporting documentation upload task. (PDF preferred; .doc and .docx also accepted.) Changes to the submission will not be permitted after the submission deadline.

Abstract Topics and Categories
The abstract submitter should submit an abstract describing a completed initiative that is significant to advanced practitioners in oncology. (See below for more information regarding complete and incomplete initiatives.)

Abstract topics may include research, clinical/evidence-based practice, educational initiatives, leadership, professional development or advanced practice projects. Abstract submitters will select one of three categories for the abstract:
  • Original Research/Evidence-based Practice
  • Quality of Care
  • Professional Development
Abstract Structure Requirements and Instructions
Word count
Abstracts should be no more than 500 words, including section headings.

Abstract title
The title at the time of submission will be the final title used in all references to the abstract. The same title will be used for the poster, poster listings, and publication in the Journal of the Advanced Practitioner in Oncology (JADPRO) should the abstract be accepted. Acronyms are not permitted in the title. The title is not included in the word count.

Section headings
The abstract must be organized with section headings.
Example section headings:
  • Background (other options: Context, Setting, Objective, Aim, Goal, Purpose)
  • Methods (other options: Design, Intervention, Approaches, Procedures, Processes)
  • Results (other options: Findings, Outcome Measures, Effects, Discoveries)
  • Conclusions (other options: Interpretation, Summary, Evaluation)
  • Recommendations (other options: Implications, Proposals, Applications)
Additional documents
References and/or permissions will be uploaded as separate documents and therefore will not be included in the word count.

In addition:
  • Authors are advised to make certain the abstract addresses the significance of the topic for oncology advanced practice and a clear description of the role of, and implications for, advanced practice in oncology.
  • Abstract content must be objective and free of bias.
  • Content must be original, novel, significant for advanced practitioners, not previously presented or published, and not submitted for consideration elsewhere.
  • Tables are not allowed within abstracts but may be used on posters.
  • Drug references in abstracts and abstract titles must be by generic name.
  • Encore abstracts and abstracts discussing trials in progress will not be considered for review.
Please read and note the criteria in the Review Process description below. This information is very important for submitting an effective abstract.

Requirements must be met and approved for an abstract to move into the review process.

Projects in Progress and Late-breaking Data
Abstracts should describe completed work; projects in progress may be considered for review if the content provided is compelling and important for the advanced practitioner prior to project completion. Late-breaking data past the submission deadline may be included in the poster should the abstract be accepted. Please contact the abstract coordinator for questions or concerns.

Abstract Authors
A maximum of 10 authors is allowed. The submitting author may be contacted to clarify co-author information, role or contributions. All correspondence regarding a submitting abstract will be directed to the submitter. Once the deadline has passed, changes to the abstract submission, including authorship, are not permitted. If there are questions regarding author inclusions, or concerns regarding presentation of a potential poster, please contact the abstract coordinator.

Abstracts may not be written or submitted by parties on behalf of authors; submissions of this type will be declined.

APSHO Membership Information
An advanced practitioner who submits an abstract must be a current, dues-paying member of APSHO in good standing and have a completed member profile. For more information regarding your current membership status or to join APSHO, please visit

Early submission is encouraged. Submitters may ask questions at any time during the process by contacting the abstract coordinator, Kelley Moore, Similarly, the submitting author will be notified if there are questions regarding information in the abstract submission.

Review Process
All completed abstract submissions that meet requirements will undergo review, including review by two or more peer reviewers utilizing a double-blind review process via the electronic submission system. (Authors and peer reviewers will remain unknown to each other.) The submitting author may contact the abstract coordinator for questions throughout the process. The abstract coordinator may contact submitting authors with questions regarding abstract submissions.

The abstract peer review will focus on the following criteria:

Category 1: Background (Context, Setting, Objective, Aim, Goal, Purpose)
  1. The background is clearly summarized.
  2. The purpose/significance (of the educational topic, clinical project/issue, leadership or professional activity or research) is clearly defined and directed to oncology advanced practice.
  3. The topic/content has implications for the oncology advanced practitioner.
  4. The role of the oncology advanced practitioner is distinctly described.
Category 2: Methods (Design, Intervention, Approaches, Procedures, Processes)
  1. How the purpose/objective was addressed is included.
  2. The implementation methods (interventions, approaches, procedures, and/or processes) are clearly described.
Category 3: Results (Findings, Outcome measures, Effects, Discoveries)
  1. The goals are evaluated according to specific measures.
  2. The outcomes are applicable to and valuable for oncology advanced practitioners.
Category 4: Conclusions (Interpretation, Summary, Evaluation)
  1. The outcomes and findings are clearly summarized and discussed.
  2. The implications for oncology advanced practice are clearly identified.
Category 5: Recommendations (Implications, Proposals, Applications)
  1. Suggestions, recommendations and/or next steps are included and applicable for APs or to oncology advanced practice.
Category 6: Innovation
  1. The research, clinical/evidence-based practice project or oncology advanced practice initiative/activity is innovative, fresh, creative or ground-breaking.
After review, peer reviewers will offer an abstract outcome recommendation and review chairs will determine/confirm final decisions. All correspondence will be directed to the submitting author, including notification of review outcomes. Accepted abstracts will be eligible for poster presentation during JADPRO Live Virtual, October 15 - 23, 2020. Posters will be available for viewing during the JADPRO Live Virtual encore period, October 26 - November 6, 2020 and during the on-demand period, November 20 - December 31, 2020. For more information regarding JADPRO Live Virtual, please visit the conference website,

Poster Presentation Requirements
Submitting authors whose abstracts are accepted for poster presentation will be contacted by the abstract coordinator. The abstract coordinator will provide additional details and outline next steps in the process, including, but not limited to, poster identifiers, specifications for poster development and related files, author tasks, presentation dates and times, and any additional requirements for final approval. Posters for presentation will be in PDF format.

Poster presentations are open to submitting author APSHO members who are registered and paid conference participants and whose abstracts have been accepted. The submitting author is the presenting author. Please contact the abstract coordinator as soon as possible if there are questions regarding the presenting author’s role. If extenuating circumstances occur, an APSHO member abstract co-author included in the original, accepted abstract may be permitted to present if approved prior to the conference.

The presenting author will complete the following tasks in the electronic system:
  • Confirm author profile information
  • Upload author photo
  • Upload author bio
  • Upload final poster in PDF format
  • Provide JADPRO Live Virtual registration confirmation number
Poster tasks will have deadlines.
All communication regarding poster presentation will be with the submitting/presenting author. If there is a problem anticipated regarding meeting deadlines, the abstract coordinator should be notified.

Poster Display
Additional details regarding virtual poster display will be provided.

Poster presentations
Poster presentations for accepted abstracts will be held during the virtual conference on designated days at specific times. Additional information regarding specific dates/times will be provided. The submitting/presenting author should be online and ready to interact virtually for the duration of the assigned virtual poster presentation times. If extenuating circumstances arise that will prevent the submitting author from presenting, the abstract coordinator must be notified prior to the first poster session.

Poster access
Accepted abstracts, posters and presenting author information will be available to registered conference attendees via the virtual conference platform. Accepted abstracts will be published in an issue of JADPRO following the live conference. Publication of the abstract will not jeopardize future submission of a manuscript; authors are encouraged to continue their work to manuscript submission.

Outstanding Poster Award
The annual Outstanding Poster Award will be awarded during JADPRO Live Virtual. To be eligible for the award, the final pdf of the poster for the accepted abstract must be uploaded to the electronic submission system by 5pm EDT on Monday, October 12, 2020.

The Poster Award Review Task Force will use the same abstract peer review criteria (see review categories above) to consider all abstract posters submitted by the poster upload deadline and will select the Outstanding Poster Award winner.

The poster award winner will receive special recognition during JADPRO Live Virtual 2020, recognition in the meeting coverage issue of JADPRO following the conference, and recognition in APSHO Advance, the APSHO member newsletter.

Accessing the Submission System
Submitting authors may access the abstract submission system below. After reading the guidelines, the submitting author should click on “Create Account” under the New Users area to create an account for the submission system. Once an account is created, the submitting author will be able to access the abstract up until the submission deadline. Submissions that are incomplete at the time of the deadline will no longer be accessible.

For questions or concerns regarding abstracts and posters for JADPRO Live Virtual, please contact the abstract coordinator, Kelley Moore, at

The abstract submission period for JADPRO Live Virtual is now closed.

Log in to the Abstract Scorecard

Questions? Organizer: Kelley Moore -